The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos

Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2019 OMIG Meeting Agenda

Ocular Microbiology and Immunology Group
53rd Annual Meeting
October 11, 2019
The Palace Hotel
Twin Peaks Room

Cecilia Lee, MD, and Savitri Sharma, MD

Click on titles to view abstracts
6:45 a.m. Registration
7:30 a.m. Introduction by Moderators
7:35 a.m.

2018 Harry Hirsch Leiter Award Recipient:
Jeremy Keenan, MD
In vitro Synergy Testing of Commonly Used Anti-amoebic Agents: Antagonism of Voriconazole

7:42 a.m.

1. What is the Prevalence of Bacteria, Fungi, Viruses, and Acanthamoeba from Cases of Keratitis, Endophthalmitis, and Conjunctivitis?
Regis P. Kowalski, MS, M(ASCP)

7:49 a.m. 2. Epidemiology of Common Microbes in Ocular Infections at an Urban Public Tertiary Care Hospital
Payal C. Shah, BS
7:56 a.m.

3. Antibiotic Resistance Among Bacterial Pathogens Collected from the Ocular Surface in the ARMOR Surveillance Study
Penny A. Asbell, MD

8:03 a.m. 4. Incidence Rate of Herpes Zoster Ophthalmicus (HZO): A Retrospective Cohort Study from 1994 to 2018
Christina Kong, BS
8:10 a.m.

5. Seven-Year Experience with “Red Eye Policy” for Employees of One Medical Center
Irene Kuo, MD

8:17 a.m. 6. A Fresh Look at Risk Factors for Pseudomonas Keratitis: Results of a Large Case Series at a Tertiary Eye Center from 2006-2019
Rikki Enzor, MD, PhD
8:24 a.m. 7. Pseudomonas aeruginosa Corneal Perforation Requires the LasR Quorum Sensing Regulator and Can Be Prevented by Predatory Bacteria in a Rabbit Model of Microbial Keratitis
Robert M.Q. Shanks, PhD
8:31 a.m. 8. Immune Response In A Rabbit Model Of Pythium Insidiosum Keratitis
Savitri Sharma, MD
8:38 a.m. 9. Validation of a Comprehensive Clinical Algorithm for the Assessment and Treatment of Microbial Keratitis
Lawson Ung, MD
8:45 a.m. 10. Evaluation of Serial Cultures for Risk Stratification of Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial
Travis Redd, MD, MPH
8:52 a.m. 11. A Review of Ocular Manifestations of Syphilis at Parkland Hospital
Nikitha Reddy, MD
8:59 a.m. 12. Characterization Of Corneal Endothelial Architecture In Ocular Inflammation Secondary To Rubella Virus
Miel Sundararajan, MD
9:06 a.m. 13. Injection Drug Use (IDU)-Associated Endogenous Endophthalmitis Masquerading as Uveitis
Christiaan Rees, PhD
9:13 a.m. 14. Dual Molecular Diagnosis of Microsporidia (Encephalitozoon hellem) Keratoconjunctivitis in an Immunocompetent Adult
Stephan Ong Tone, MDCM, PhD, FRCSC
9:20 a.m 15. Metagenomic Deep Sequencing for the Diagnosis of Corneal and External Disease Infections
Gerami D. Seitzman, MD
9:27 a.m. 16. Molecular Pathogens as Predictors of Post-Surgical Endophthalmitis Outcome
Cecilia S. Lee , MD
9:34 a.m. 17. Sequence Variants of Adenorivus Type 8 Predict Pathogenicity
Kenji Nakamichi
9:40 a.m. BREAK
9:49 a.m. 18. Ocular Clinical Signs and Diagnostic Tests Most Compatible with Keratoconjunctivitis Sicca: A Latent Class Approach
John A. Gonzales, MD
9:56 a.m. 19. Gut Microbial Dysbiosis in Individuals with Sjögren’s Disease
Arjun Watane
10:03 a.m. 20. IL-23 Drives Effector Th17/1 to Memory Th17 Cells in Dry Eye Disease
Nai-Wen Fan
10:10 a.m. 21. Novel Cell Based Therapy for Corneal Neovascularization by Local Adoptive Transfer of Plasmacytoid Dendritic Cells
Arsia Jamali, MD, MPH
10:17 a.m. 22. Novel Ocular Formulations of Elemental Iodine Demonstrate Rapid Antimicrobial Activity against Ocular Bacteria and Yeast
Eric Romanowski, MS
10:24 a.m. 23 Efficacy of Dilute Topical Ophthalmic Povidone-Iodine against Multi- Drug Resistant Bacterial Biofilms, Fungal Biofilms and Fungal Spores
Jesse Pelletier, MD, FACS
10:31 a.m. 24. Cysticidal Activity of povidone iodine and natamycin for acanthamoeba
Jeremy Keenan, MD
10:38 a.m.

25. Beta-adrenergic Blocking Agents have Antifungal Activity Against Fusarium isolates at Concentrations Similar to Levels Used to Treat Glaucoma
Michael Zegans, MD

10:45 a.m. 26. Rose Bengal Photodynamic Antimicrobial Therapy Safety Study. Pilot study
Jaime D. Martinez, MD
10:52 a.m. 27. Sustained Delivery of Cyclosporine Using Cross-Linked Collagen Wafers
Richard A. Eiferman, MD
10:59 a.m. 28. Effective Corneal Delivery of Moxifloxacin and Dexamethasone Combination Using Drug Eluting Mucoadhesive Contacts
Prashant Garg, MD
11:06 a.m. BREAK
11:15 a.m. Thygeson Lecture: Acanthamoeba and Keratitis... More than meets the Eye

Darlene Miller, DHSc, MPH

Research Professor
Department of Ophthalmology
Department of Microbiology and Immunology
Technical Director, Ocular Microbiology Laboratory
University of Miami School of Medicine
Bascom Palmer Eye Institute/ABLEH
12:00 p.m. Closing Comments and Awards
12:30 p.m.

Business Luncheon -- Pacific Heights Room

Top of Page